Display options
Cite
Kim BB, Ko Y, Park JB. Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells. Biomed Rep. 2015;3(6):845-848doi: 10.3892/br.2015.520.
Kim, B. B., Ko, Y., & Park, J. B. (2015). Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells. Biomedical reports, 3(6), 845-848. https://doi.org/10.3892/br.2015.520
Kim, Bo-Bae, et al. "Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells." Biomedical reports vol. 3,6 (2015): 845-848. doi: https://doi.org/10.3892/br.2015.520
Kim BB, Ko Y, Park JB. Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells. Biomed Rep. 2015 Nov;3(6):845-848. doi: 10.3892/br.2015.520. Epub 2015 Sep 28. PMID: 26623028; PMCID: PMC4660587.
Copy Download .nbib Format: NLM
Share it on

Biomed Rep. 2015 Nov;3(6):845-848. doi: 10.3892/br.2015.520. Epub 2015 Sep 28.

Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells.

Biomedical reports

Bo-Bae Kim, Youngkyung Ko, Jun-Beom Park

Affiliations

  1. Department of Periodontics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

PMID: 26623028 PMCID: PMC4660587 DOI: 10.3892/br.2015.520

Abstract

Risedronate has been used for the prevention and treatment of postmenopausal and corticosteroid-induced osteoporosis. The present study was performed to evaluate the effects of risedronate on the morphology and viability of human stem cells derived from the gingiva. Stem cells derived from the gingiva were grown in the presence of risedronate at concentrations that ranged from 1 to 10 µM. The morphology of the cells was viewed under an inverted microscope, and cell proliferation was analyzed with a cell counting kit-8 (CCK-8) on days 2, 4 and 7. The untreated control group showed a spindle-shaped, fibroblast-like morphology. The shapes of the cells treated with 1 and 5 µM risedronate were similar to that of the control group on day 2. However, morphology of the 10 µM group markedly differed from that of the control group. The shapes of the cells in the 1, 5 and 10 µM groups were rounder, and pronounced alterations when compared with the untreated control group were noted in all groups on day 7. The cultures growing in the presence of risedronate showed decreased CCK-8 values on day 7. In conclusion, risedronate produced notable alterations in the morphology of the cells and reduced the viability of gingival mesenchymal stem cells.

Keywords: cell survival; gingiva; risedronic acid; stem cells

References

  1. Arch Intern Med. 2001 Feb 12;161(3):353-60 - PubMed
  2. Treat Endocrinol. 2003;2(6):415-20; discussion 421 - PubMed
  3. Bone Marrow Transplant. 2006 Jan;37(1):81-8 - PubMed
  4. J Bone Miner Res. 2008 Mar;23(3):373-9 - PubMed
  5. J Bone Miner Metab. 2004;22(2):120-6 - PubMed
  6. Clin Ther. 2007 Sep;29(9):1937-49 - PubMed
  7. Drugs Aging. 2009;26(4):355-62 - PubMed
  8. J Periodontal Res. 2015 Aug;50(4):461-7 - PubMed
  9. Arch Med Res. 2013 Jul;44(5):325-34 - PubMed
  10. Ann Pharmacother. 2002 Mar;36(3):512-6 - PubMed
  11. Mayo Clin Proc. 2013 Jan;88(1):46-55 - PubMed
  12. Drugs. 2001;61(5):685-712 - PubMed
  13. J Int Med Res. 2012;40(5):1761-74 - PubMed
  14. Osteoporos Int. 2008 Jul;19(7):1039-45 - PubMed
  15. J Surg Res. 2012 May 15;174(2):278-83 - PubMed
  16. Pharm Res. 2001 Feb;18(2):166-70 - PubMed
  17. Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):78-84 - PubMed

Publication Types